1-153960358-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001271958.2(SLC39A1):c.715G>T(p.Val239Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,638 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001271958.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC39A1 | NM_001271958.2 | c.715G>T | p.Val239Leu | missense_variant | 4/4 | ENST00000356205.9 | NP_001258887.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC39A1 | ENST00000356205.9 | c.715G>T | p.Val239Leu | missense_variant | 4/4 | 1 | NM_001271958.2 | ENSP00000348535.4 | ||
ENSG00000285779 | ENST00000648921.1 | n.*803G>T | non_coding_transcript_exon_variant | 6/6 | ENSP00000498105.1 | |||||
ENSG00000285779 | ENST00000648921.1 | n.*803G>T | 3_prime_UTR_variant | 6/6 | ENSP00000498105.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000400 AC: 1AN: 250156Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135458
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461638Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727120
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 05, 2022 | The c.715G>T (p.V239L) alteration is located in exon 5 (coding exon 3) of the SLC39A1 gene. This alteration results from a G to T substitution at nucleotide position 715, causing the valine (V) at amino acid position 239 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at